Glen Eagle Advisors’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-65	Closed	-$3.33K	–	1064
2021 Q1	$3.33K	Sell	65 -65	-50%	-$3.33K	﹤0.01%	821
2020 Q4	$3.48K	Buy	+130	New	+$3.48K	﹤0.01%	785